Literature DB >> 22434518

Delineating the autoimmune mechanisms in Graves' disease.

Syed A Morshed1, Rauf Latif, Terry F Davies.   

Abstract

The immunologic processes involved in autoimmune thyroid disease (AITD), particularly Graves' disease (GD), are similar to other autoimmune diseases with the emphasis on the antibodies as the most unique aspect. These characteristics include a lymphocytic infiltrate at the target organs, the presence of antigen-reactive T and B cells and antibodies, and the establishment of animal models of GD by antibody transfer or immunization with antigen. Similar to other autoimmune diseases, risk factors for GD include the presence of multiple susceptibility genes, including certain HLA alleles, and the TSHR gene itself. In addition, a variety of known risk factors and precipitators have been characterized including the influence of sex and sex hormones, pregnancy, stress, infection, iodine and other potential environmental factors. The pathogenesis of GD is likely the result of a breakdown in the tolerance mechanisms, both at central and peripheral levels. Different subsets of T and B cells together with their regulatory populations play important roles in the propagation and maintenance of the disease process. Understanding different mechanistic in the complex system biology interplay will help to identify unique factors contributing to the AITD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22434518      PMCID: PMC4504182          DOI: 10.1007/s12026-012-8312-8

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  123 in total

1.  Multiple autoimmune diseases after autologous stem-cell transplantation.

Authors:  Toshiyuki Bohgaki; Tatsuya Atsumi; Takao Koike
Journal:  N Engl J Med       Date:  2007-12-27       Impact factor: 91.245

2.  Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves' patients sera by luminescent immunoprecipitation analysis.

Authors:  W B Minich; U Loos
Journal:  Exp Clin Endocrinol Diabetes       Date:  2000       Impact factor: 2.949

3.  Effects of TSH receptor mutations on binding and biological activity of monoclonal antibodies and TSH.

Authors:  Jane Sanders; Jane Bolton; Paul Sanders; Jennifer Jeffreys; Nobuhiro Nakatake; Tonya Richards; Michele Evans; Angela Kiddie; Sara Summerhayes; Emma Roberts; Ricardo Núñez Miguel; Jadwiga Furmaniak; Bernard Rees Smith
Journal:  Thyroid       Date:  2006-12       Impact factor: 6.568

Review 4.  The role of stress in the clinical expression of thyroid autoimmunity.

Authors:  Agathocles Tsatsoulis
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

5.  An N-linked glycosylation motif from the noncleaving luteinizing hormone receptor substituted for the homologous region (Gly367 to Glu369) of the thyrotropin receptor prevents cleavage at its second, downstream site.

Authors:  A Kakinuma; G D Chazenbalk; K Tanaka; Y Nagayama; S M McLachlan; B Rapoport
Journal:  J Biol Chem       Date:  1997-11-07       Impact factor: 5.157

6.  Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody.

Authors:  Paul Sanders; Stuart Young; Jane Sanders; Katarzyna Kabelis; Stuart Baker; Andrew Sullivan; Michele Evans; Jill Clark; Jane Wilmot; Xiaoling Hu; Emma Roberts; Michael Powell; Ricardo Núñez Miguel; Jadwiga Furmaniak; Bernard Rees Smith
Journal:  J Mol Endocrinol       Date:  2011-02-15       Impact factor: 5.098

7.  Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function.

Authors:  J Sanders; J Jeffreys; H Depraetere; M Evans; T Richards; A Kiddie; K Brereton; L D K E Premawardhana; D Y Chirgadze; R Núñez Miguel; T L Blundell; J Furmaniak; B Rees Smith
Journal:  Thyroid       Date:  2004-08       Impact factor: 6.568

8.  Graves' IgG recognizes linear epitopes in the human thyrotropin receptor.

Authors:  E V Nagy; H B Burch; K Mahoney; Y G Lukes; J C Morris; K D Burman
Journal:  Biochem Biophys Res Commun       Date:  1992-10-15       Impact factor: 3.575

9.  Antithyroperoxidase antibody-dependent cytotoxicity in autoimmune thyroid disease.

Authors:  Sandra A Rebuffat; Brigitte Nguyen; Bruno Robert; Françoise Castex; Sylvie Peraldi-Roux
Journal:  J Clin Endocrinol Metab       Date:  2007-12-11       Impact factor: 5.958

10.  Apoptosis in orbital fibroadipose tissue and its association with clinical features in Graves' ophthalmopathy.

Authors:  Onur Konuk; Ahmet Hondur; Nalan Akyurek; Mehmet Unal
Journal:  Ocul Immunol Inflamm       Date:  2007 Mar-Apr       Impact factor: 3.070

View more
  43 in total

1.  How one TSH receptor antibody induces thyrocyte proliferation while another induces apoptosis.

Authors:  Syed A Morshed; Risheng Ma; Rauf Latif; Terry F Davies
Journal:  J Autoimmun       Date:  2013-08-17       Impact factor: 7.094

Review 2.  Diagnosis and management of Graves disease: a global overview.

Authors:  Luigi Bartalena
Journal:  Nat Rev Endocrinol       Date:  2013-10-15       Impact factor: 43.330

Review 3.  T regulatory (Treg) and T helper 17 (Th17) lymphocytes in thyroid autoimmunity.

Authors:  Roberto González-Amaro; Mónica Marazuela
Journal:  Endocrine       Date:  2015-10-16       Impact factor: 3.633

4.  Biased signaling by thyroid-stimulating hormone receptor-specific antibodies determines thyrocyte survival in autoimmunity.

Authors:  Syed A Morshed; Risheng Ma; Rauf Latif; Terry F Davies
Journal:  Sci Signal       Date:  2018-01-23       Impact factor: 8.192

5.  Cleavage Region Thyrotropin Receptor Antibodies Influence Thyroid Cell Survival In Vivo.

Authors:  Syed A Morshed; Risheng Ma; Rauf Latif; Terry F Davies
Journal:  Thyroid       Date:  2019-06-04       Impact factor: 6.568

Review 6.  Selenium supplementation in thyroid associated ophthalmopathy: an update.

Authors:  Aruna Dharmasena
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

Review 7.  Targeting the thyroid-stimulating hormone receptor with small molecule ligands and antibodies.

Authors:  Terry F Davies; Rauf Latif
Journal:  Expert Opin Ther Targets       Date:  2015-03-13       Impact factor: 6.902

Review 8.  Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

Review 9.  TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective.

Authors:  Basil Rapoport; Sandra M McLachlan
Journal:  Endocr Rev       Date:  2016-02       Impact factor: 19.871

10.  Low regulatory T cell and high IL-17 mRNA expression in a mouse Graves' disease model.

Authors:  Q Yuan; Y Zhao; X Zhu; X Liu
Journal:  J Endocrinol Invest       Date:  2016-11-07       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.